gemfibrozil has been researched along with Benign Neoplasms, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Miguel, D | 1 |
| García-Suárez, J | 1 |
| Martín, Y | 1 |
| Gil-Fernández, JJ | 1 |
| Burgaleta, C | 1 |
| Strakova, N | 1 |
| Ehrmann, J | 1 |
| Bartos, J | 1 |
| Malikova, J | 1 |
| Dolezel, J | 1 |
| Kolar, Z | 1 |
1 review available for gemfibrozil and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Severe acute renal failure following high-dose methotrexate therapy in adults with haematological malignancies: a significant number result from unrecognized co-administration of several drugs.
Topics: Acute Kidney Injury; Adult; Antimetabolites, Antineoplastic; Brain Neoplasms; Drug Interactions; Gem | 2008 |
1 other study available for gemfibrozil and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors.
Topics: Apoptosis; Bezafibrate; Brain Neoplasms; Cell Cycle; Cell Differentiation; Cell Survival; Flow Cytom | 2005 |